Read It - Latest News Update

Connect with us

Sell Ocugen On Split Stake In Potential U.S. Revenues - Seeking Alpha

Source: Seeking Alpha

OCGN has risen to a $2.5 billion market cap on hopes it will be able to market COVAXIN in the United States. Bharat Biotech maintains a 55% stake in any U.S. profits.... Read More

Source: Seeking Alpha
Published: 2021-05-03T16:44:00Z